Table 4

 Logistic regression for prediction of carrier status based on family history in 191 families with at least one affected individual tested

Family characteristics*ORp Value (95% CI)
Br, breast; Ca, cancer; Ov, ovarian.
*Female breast and ovarian cancer cases were at most third-degree relatives of the proband, whereas the presence of male patients with breast cancer was considered at any degree from the proband; 10 cases of ductal carcinoma in situ included.
BRCA1+ v no mutation detected
    0–1 cases Br Ca <50 years1 (Ref)
    2–3 cases Br Ca <50years4.70.12 (0.7 to 32.8)
    ⩾4 cases Br Ca <50 years46.30.001 (4.8 to 443)
    0–1 cases Br Ca ⩾50 years1 (Ref)
    2–3 cases Br Ca ⩾50 years0.20.022 (0.04 to 0.8)
    ⩾4 cases Br Ca ⩾50 years0.10.10 (0.01 to 1.5)
    No Ov Ca1 (Ref)
    1 case Ov Ca10.60.005 (2.0 to 54.7)
    ⩾2 cases Ov Ca284<0.001 (33 to 2466)
    ⩾1 male Br Ca v none24.80.076 (0.7 to 868)
    ⩾1 bilateral Br Ca v none7.50.014 (1.5 to 37)
BRCA2+ v no mutation detected
    0–1 cases Br Ca <50 years1 (Ref)
    2–3 cases Br Ca <50 years1.70.39 (0.5 to 5.7)
    ⩾4 cases Br Ca <50 years5.90.010 (1.5 to 23)
    0–1 cases Br Ca ⩾50 years1 (Ref)
    2–3 cases Br Ca ⩾50 years0.50.22 (0.1 to 41.6)
    ⩾4 cases Br Ca ⩾50 years0.90.94 (0.2 to 53.6)
    No Ov Ca1 (Ref)
    1 case Ov Ca1.60.48 (0.4 to 4.7)
    ⩾2 cases Ov Ca17.0<0.001 (3.7 to 78)
    ⩾1 male Br Ca v none13.70.004 (2.3 to 80)
    ⩾1 bilateral Br Ca v none3.70.019 (1.2 to 11)
BRCA1/BRCA2+ v no mutation detected
    0–1 cases Br Ca <50 years1 (Ref)
    2–3 cases Br Ca <50 years2.40.12 (0.8 to 7.2)
    ⩾4 cases Br Ca <50 years10.4<0.001 (3.1 to 36)
    0–1 cases Br Ca ⩾50 years1 (Ref)
    2–3 cases Br Ca ⩾50 years0.40.047 (0.13 to 0.99)
    ⩾4 cases Br Ca ⩾50 years0.60.37 (0.16 to 2.10)
    No Ov Ca1 (Ref)
    1 case Ov Ca2.80.059 (0.9 to 67.9)
    ⩾2 cases Ov Ca51<0.001 (13.5 to 195)
    ⩾1 male Br Ca v none14.80.004 (2.4 to 91)
    ⩾1 bilateral Br Ca v none5.20.001 (1.9 to 14.1)